Literature DB >> 23184343

Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population.

Oliwia Zakerska1, Marzena Skrzypczak-Zielinska, Adam Mikstacki, Barbara Tamowicz, Bianka Malengowska, Marlena Szalata, Ryszard Slomski.   

Abstract

The human UDP-glucuronosyltransferase 1A9 (UGT1A9) plays a central role in the metabolism of different therapeutic drugs, carcinogens and endobiotics. The UGT1A9 gene shows genetic polymorphism with frequencies significantly different in populations and ethnic groups. Many of these genetic variants are directly responsible for polymorphic drug metabolism. Three crucial alleles of UGT1A9, UGT1A9*3 (p.Met33Thr), *4 (p.Tyr242X), *5 (p.Asp256Asn) are associated with decrease or absence of enzyme activity, which intensify the risk of toxic effect during biotransformation. The goal of the present study was to discover frequencies of these genetic variations in 308 healthy individuals representing Polish population. The genotypes were determined by pyrosequencing. We demonstrated that the frequency of the variant UGT1A9*3 was 0.016, which suggests the need for detailed analysis of its effect on important drugs metabolism level in Polish population. Alleles UGT1A9*4 and UGT1A9*5 were not present in any of the subjects. So far, no studies have been conducted in which the distribution of these alleles has been determined in the Polish population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184343     DOI: 10.1007/s13318-012-0110-0

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  23 in total

1.  Propofol infusion in children: when does an anesthetic tool become an intensive care liability?

Authors:  Andrew R Wolf; Frank Potter
Journal:  Paediatr Anaesth       Date:  2004-06       Impact factor: 2.556

2.  Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.

Authors:  Ada Piepoli; Annamaria Gentile; Maria Rosa Valvano; Daniela Barana; Cristina Oliani; Rosa Cotugno; Michele Quitadamo; Angelo Andriulli; Francesco Perri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

3.  Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.

Authors:  Rajeev K Mehlotra; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-11-09       Impact factor: 2.953

4.  Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

Authors:  Q H Gong; J W Cho; T Huang; C Potter; N Gholami; N K Basu; S Kubota; S Carvalho; M W Pennington; I S Owens; N C Popescu
Journal:  Pharmacogenetics       Date:  2001-06

5.  The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.

Authors:  Hugo Girard; Lyne Villeneuve; Michael H Court; Louis-Charles Fortier; Patrick Caron; Qin Hao; Lisa L von Moltke; David J Greenblatt; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2006-04-04       Impact factor: 3.922

6.  Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8.

Authors:  C P Strassburg; M P Manns; R H Tukey
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

7.  Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).

Authors:  Hiroko Takahashi; Yoshihiro Maruo; Asami Mori; Masaru Iwai; Hiroshi Sato; Yoshihiro Takeuchi
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-08       Impact factor: 4.080

8.  A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.

Authors:  J K Ritter; F Chen; Y Y Sheen; H M Tran; S Kimura; M T Yeatman; I S Owens
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

9.  Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38.

Authors:  Luca Paoluzzi; Arun S Singh; Douglas K Price; Romano Danesi; Ron H J Mathijssen; Jaap Verweij; William D Figg; Alex Sparreboom
Journal:  J Clin Pharmacol       Date:  2004-08       Impact factor: 3.126

10.  Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.

Authors:  T J Parke; J E Stevens; A S Rice; C L Greenaway; R J Bray; P J Smith; C S Waldmann; C Verghese
Journal:  BMJ       Date:  1992-09-12
View more
  3 in total

1.  Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.

Authors:  J Jiang; X Zhang; R Huo; X Li; Y Yang; Z Gai; M Xu; L Shen; L Cai; C Wan; B Li; L He; S Qin
Journal:  Pharmacogenomics J       Date:  2014-12-02       Impact factor: 3.550

2.  Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.

Authors:  Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Adam Mikstacki; Michal Walczak; Michal Prendecki; Jolanta Dorszewska; Agnieszka Pollak; Urszula Lechowicz; Monika Oldak; Kinga Huminska-Lisowska; Marta Molinska-Glura; Marlena Szalata; Ryszard Slomski
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

3.  The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.

Authors:  Adam Mikstacki; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Michał Prendecki; Jolanta Dorszewska; Marta Molinska-Glura; Malgorzata Waszak; Ryszard Slomski
Journal:  J Appl Genet       Date:  2016-11-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.